<?xml version="1.0" encoding="UTF-8"?>
<p id="Par15">Although preprints are becoming more acceptable in academic publishing, they remain works-in-progress. Policymakers should not consider them to be evidence-based science nor use them as the basis for public health decisions, as preprints have not undergone a rigorous process of peer review [
 <xref ref-type="bibr" rid="CR22">22</xref>, 
 <xref ref-type="bibr" rid="CR23">23</xref>]. Often, research that emerges from review is a much refined and a more robust version of the initial submission. For example, observational studies reporting that the drug ‘hydroxychloroquine’ is linked to severe adverse events and mortality among patients with COVID-19 were found to be based on unsourced data, and the papers had to be retracted [
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR25">25</xref>].
</p>
